Welcome!

News Feed Item

Clinical trial: robotic surgery may reduce side effects of throat cancer treatment

Throat cancers on the rise due to epidemic of HPV infection

TORONTO, April 17, 2013 /CNW/ - Researchers in London, Ontario, are conducting a first-ever clinical trial to determine which treatment option gives patients with throat cancers the best quality of life. These cancers are dramatically on the rise due to the epidemic of HPV (human papilloma virus) infection.

Surgeon Dr Anthony Nichols and radiation oncologist Dr David Palma at the Lawson Research Centre have received a $223,000 Quality of Life Grant from the Canadian Cancer Society to conduct the study. Dr Nichols is an assistant professor in head and neck surgery at Western University. Dr Palma is a clinician-scientist with the Ontario Institute for Cancer Research.

The current standard treatment for throat cancers is radiation and chemotherapy, which results in good control of the disease but can leave patients with a variety of life-changing side effects, such as problems with speaking, swallowing, tasting and hearing and even feeding tube dependence.

A minimally invasive robotic surgery has emerged as a promising alternative treatment that appears to have fewer side effects.

"Patients with HPV-related throat cancers tend to be younger and healthier and have a good chance of being cured. As they will have to live with the side effects of treatment for decades, post-treatment quality of life is of paramount importance," says Dr Nichols.

"Before we can adopt a new treatment, we have to prove that the rates of cure are as good as they are with the standard treatment, which is chemotherapy with radiation," says Dr. Palma. "Sometimes new technologies are introduced with a lot of hype but don't prove to be helpful in the end. Transoral robotic surgery has shown tremendous promise as a treatment option, and we are the only ones in the world doing this type of study right now."

For the 3-year study, patients with early stage cancer of the oropharynx (which includes the tongue, soft palate, side and back walls of the throat, and tonsils) are invited to participate in a randomized phase II clinical trial. Patients will be assigned to receive either the current standard treatment (radiation, plus or minus chemotherapy) or the robotic surgery. One year after treatment, patient quality of life will be assessed for side effects.

This will be the first clinical trial to directly compare the 2 treatment methods and has the potential to have an international impact on the treatment of patients with throat cancers. In the United States, the robotic surgery is already being used for these types of cancers despite the lack of high-level evidence to support it.

To do the surgery, doctors use tiny robotically controlled surgical implements to remove tumours of the tongue, tonsils, palate or throat. The robot has a viewfinder and 3-D camera that can see around corners, and the tiny robotic arms can get into tight spaces where the surgeon's hands cannot fit. While the surgeon watches what's happening on a screen, the robotic arms precisely mimic the movements of the surgeon's hands and can even filter out the surgeon's hand tremor.

"The Canadian Cancer Society knows how important a patient's quality of life is during and after cancer treatment," says Dr Siân Bevan, Director of Research at the Canadian Cancer Society. "This exciting new surgical method shows great promise to vastly improve quality of life, and we are happy to be able to fund this important study, with the generous support of our donors."

About HPV and cancer

According to Dr. Nichols, HPV is the most common sexually transmitted infection. "The incidence of throat cancers has increased dramatically in recent years due in large part to widespread infection with HPV. The increase is thought to be because of changes in sexual practices that began in the 1960s."

These cancers typically take more than 20 years to develop. Some strains of the HPV virus cause cervical cancer as well as ano-genital cancers. More recently, HPV infections have been found to cause cancers of the oropharynx.

It is estimated that 75% of sexually-active Canadians will have at least one HPV infection in their lifetime. The body's immune system usually gets rid of an HPV infection on its own. Most HPV infections (about 70%) go away without any treatment within 1-2 years. Persistent infection with high-risk HPV types over many years can cause precancerous changes and cancer.

HPV infection is associated with about:

  • 25%-35% of oropharyngeal cancers
  • 40% of vaginal and vulvar cancers
  • 40%-50% of penile cancers
  • 80%-90% of anal cancers

Dr. Nichols says that throat cancer patients whose disease was caused by an HPV infection tend to be diagnosed in their 40s and 50s, as opposed to patients whose throat cancer was caused by smoking and alcohol (these patients tend to be diagnosed at 60 or older).

A vaccine is available in Canada to prevent HPV infection. It protects against the types of HPV that cause 70% of HPV-related cancers. For more information, visit cancer.ca.

Other Quality of Life Grants

Dr Kim Edelstein, Toronto, $299,754 - Since cancer in young adults occurs during crucial formative years, it can have a particularly devastating effect, leaving survivors with a variety of long-term side-effects as a result of the disease and treatment. In her study, Dr Edelstein is exploring the impact of chemotherapy on thinking abilities during the first year after being diagnosed with cancer and whether these changes impact psychosocial development, with the findings to be used to develop strategies to help prevent or decrease these problems.

Dr Stephen Hall, Kingston, $153,029 - Using a series of questionnaires delivered over a 3-year period, Dr Hall will lead the first study of its kind to examine how patients who have had head and neck cancer perceive follow-up appointments to understand their attitudes, needs, fears and expected benefits about the appointments. His goal is to improve the quality of life for survivors by making the follow-up care more effective for individual patients while improving the efficiency of the health care system.

Dr Robert Klaassen, Ottawa, $177,794 - Using a survey developed with the input of patients, caregivers, health care providers and quality of life experts, Dr Klaassen aims to assess the impact of treatments on the quality of life of patients with incurable blood disorders that put them at a high risk of developing cancer. Because of the incurable nature of the conditions - named myelodysplastic syndromes - determining the impact of treatment on quality of life is crucial and this survey may become a critical resource and powerful tool to achieve this.

Dr Andrew Matthew, Toronto, $137,233 - Sexual dysfunction after prostate cancer surgery is one of the most substantial concerns for patients and their partners and has a significant impact on quality of life. To address this important health issue, Dr Matthew is developing a biomedical-psychosocial intervention which incorporates the active participation of the partner and features medical, psychological and social methods, with the eventual goal of introducing a new and effective way to support intimacy and optimal sexual health.

Dr Roanne Thomas, Ottawa, $244,128 - Using a variety of methods, including group discussion, photography, journaling and film, Dr Thomas will document the breast cancer experiences of First Nations, Inuit and Metis women.  Since little is known about the factors which affect the breast cancer experiences of these groups of women, Dr Thomas' study will address gaps in knowledge and care to uncover valuable information for the development of future support programs and education materials for health professionals.

About the Quality of Life Grants

This program has been created to support quality of life cancer research that has the potential to make a significant impact on the burden of disease in patients, survivors and caregivers

About the Canadian Cancer Society

For 75 years the Canadian Cancer Society has been with Canadians in the fight for life. We have been relentless in our commitment to prevent cancer, fund research and support Canadians touched by cancer. From this foundation, we will work with Canadians to change cancer forever so fewer Canadians are diagnosed with the disease and more survive.

Visit cancer.ca or call us at 1-888-939-3333 (TTY 1-866-786-3934).

SOURCE Canadian Cancer Society (National Office)

Image with caption: "With a Quality of Life grant from the Canadian Cancer Society, Dr. Anthony Nichols (right) and Dr. David Palma will lead a first-ever clinical trial to determine if robotic surgery to treat throat cancer reduces side effects. (CNW Group/Canadian Cancer Society (National Office))". Image available at: http://photos.newswire.ca/images/download/20130417_C5793_PHOTO_EN_25578.jpg

Image with caption: "Dr. Anthony Nichols performs robotic surgery on a throat cancer patient. With a Quality of Life grant from the Canadian Cancer Society, he will study if this non-invasive approach reduces side effects. (CNW Group/Canadian Cancer Society (National Office))". Image available at: http://photos.newswire.ca/images/download/20130417_C5793_PHOTO_EN_25576.jpg

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
Multiple data types are pouring into IoT deployments. Data is coming in small packages as well as enormous files and data streams of many sizes. Widespread use of mobile devices adds to the total. In this power panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists will look at the tools and environments that are being put to use in IoT deployments, as well as the team skills a modern enterprise IT shop needs to keep things running, get a handle on all this data, and deli...
As enterprise cloud becomes the norm, businesses and government programs must address compounded regulatory compliance related to data privacy and information protection. The most recent, Controlled Unclassified Information and the EU’s GDPR have board level implications and companies still struggle with demonstrating due diligence. Developers and DevOps leaders, as part of the pre-planning process and the associated supply chain, could benefit from updating their code libraries and design by in...
In his opening keynote at 20th Cloud Expo, Michael Maximilien, Research Scientist, Architect, and Engineer at IBM, will motivate why realizing the full potential of the cloud and social data requires artificial intelligence. By mixing Cloud Foundry and the rich set of Watson services, IBM's Bluemix is the best cloud operating system for enterprises today, providing rapid development and deployment of applications that can take advantage of the rich catalog of Watson services to help drive insigh...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend @CloudExpo | @ThingsExpo, June 6-8, 2017, at the Javits Center in New York City, NY and October 31 - November 2, 2017, Santa Clara Convention Center, CA. Learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
SYS-CON Events announced today that EARP Integration will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. EARP Integration is a passionate software house. Since its inception in 2009 the company successfully delivers smart solutions for cities and factories that start their digital transformation. EARP provides bespoke solutions like, for example, advanced enterprise portals, business intelligence systems an...
SYS-CON Events announced today that WineSOFT will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Based in Seoul and Irvine, WineSOFT is an innovative software house focusing on internet infrastructure solutions. The venture started as a bootstrap start-up in 2010 by focusing on making the internet faster and more powerful. WineSOFT’s knowledge is based on the expertise of TCP/IP, VPN, SSL, peer-to-peer, mob...
SYS-CON Events announced today that delaPlex will exhibit at SYS-CON's @CloudExpo, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. delaPlex pioneered Software Development as a Service (SDaaS), which provides scalable resources to build, test, and deploy software. It’s a fast and more reliable way to develop a new product or expand your in-house team.
SYS-CON Events announced today that Carbonite will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Carbonite protects your entire IT footprint with the right level of protection for each workload, ensuring lower costs and dependable solutions with DoubleTake and Evault.
SYS-CON Events announced today that Progress, a global leader in application development, has been named “Bronze Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Enterprises today are rapidly adopting the cloud, while continuing to retain business-critical/sensitive data inside the firewall. This is creating two separate data silos – one inside the firewall and the other outside the firewall. Cloud ISVs oft...
One of the biggest challenges with adopting a DevOps mentality is: new applications are easily adapted to cloud-native, microservice-based, or containerized architectures - they can be built for them - but old applications need complex refactoring. On the other hand, these new technologies can require relearning or adapting new, oftentimes more complex, methodologies and tools to be ready for production. In his general session at @DevOpsSummit at 20th Cloud Expo, Chris Brown, Solutions Marketi...
SYS-CON Events announced today that Outscale will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Outscale's technology makes an automated and adaptable Cloud available to businesses, supporting them in the most complex IT projects while controlling their operational aspects. You boost your IT infrastructure's reactivity, with request responses that only take a few seconds.
As cloud adoption continues to transform business, today's global enterprises are challenged with managing a growing amount of information living outside of the data center. The rapid adoption of IoT and increasingly mobile workforce are exacerbating the problem. Ensuring secure data sharing and efficient backup poses capacity and bandwidth considerations as well as policy and regulatory compliance issues.